Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of apolipoprotein E genotype on progression of diabetic nephropathy.

Nephron. Experimental nephrology - 1 Jan 2005

Joss Nicola, Jardine Alan, Gaffney Dairena, Boulton-Jones J Michael

Abstract excerpt

AIMS: Diabetic nephropathy progresses at a variable rate part of which may be explained by genetic polymorphisms. ApoE polymorphisms are associated with progression of atherosclerosis and because of the similarities between atherosclerosis and glomerulosclerosis, we chose to examine apoE and its role in progression of diabetic nephropathy. METHODS: The apoE genotypes of 90 patients with type 2 diabetes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E3
Share to Apolipoprotein E4
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Diabetic Nephropathies

Share to Disease Progression

Share to Randomized Controlled Trials as Topic

Share to Renal Insufficiency

Source

Identifiers

PMID: 16113584
DOI: 10.1159/000087577

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of apolipoprotein E genotype on progression of diabetic nephropathy.PMID 16113584Read ↗

Apolipoprotein E gene polymorphism, hypercholesterolemia and glomerular filtration rate in type 2 diabetic subjects: a 9-year follow-up study.Semantic proximity Read ↗

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.Semantic proximity Read ↗

Apolipoprotein E and progression of chronic kidney disease.Semantic proximity Read ↗

APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.Semantic proximity Read ↗

Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects.Semantic proximity Read ↗

Apolipoprotein E levels and apolipoprotein E genotypes in incident cardiovascular disease risk in subjects of the Prevention of Renal and Vascular End-stage disease study.Semantic proximity Read ↗

Apolipoprotein E genotype predicts cardiovascular endpoints in dialysis patients with type 2 diabetes mellitus.Semantic proximity Read ↗

APOE polymorphism and diabetic nephropathy.Semantic proximity Read ↗

Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.Semantic proximity Read ↗

Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.Semantic proximity Read ↗

ApoE polymorphism and albuminuria in diabetes mellitus: a role for LDL in the development of nephropathy in NIDDM?Semantic proximity Read ↗

Apo E gene polymorphism on development of diabetic nephropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.